➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
McKinsey
Baxter

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

KEDBUMIN Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for KEDBUMIN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
inVentiv Health ClinicalPhase 2/Phase 3
Kedrion S.p.A.Phase 2/Phase 3

See all KEDBUMIN clinical trials

Recent Litigation for KEDBUMIN

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Genentech, Inc. v. Samsung Bioepis Co. Ltd.2020-06-28
ABRAXIS BIOSCIENCE, LLC v. SUN PHARMA ADVANCED RESEARCH COMPANY, LTD.2019-08-08
Genentech, Inc. v. Pfizer Inc.2019-04-05

See all KEDBUMIN litigation

PTAB Litigation
PetitionerDate
Apotex Inc.2017-11-09
Cipla Ltd.2017-11-09
Actavis LLC2017-04-04

See all KEDBUMIN litigation

Patent Text Search: US Patents for KEDBUMIN

These patents were identified by searching patent claims

Supplementary Protection Certificates for KEDBUMIN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1490056-7 Sweden   Get Started Free PRODUCT NAME: ALBIGLUTIDE; REG. NO/DATE: EU/1/13/908/001002 20140321
09C0050 France   Get Started Free PRODUCT NAME: PACLITAXEL ALBUMINE; REGISTRATION NO/DATE: EU/1/07/428/001 20080111
132014902293932 Italy   Get Started Free PRODUCT NAME: ALBIGLUTIDE(EPERZAN); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/13/908, 20140321
91613 Luxembourg   Get Started Free 91613, EXPIRES: 20220924
C01463751/01 Switzerland   Get Started Free PRODUCT NAME: ALBIGLUTIDUM; REGISTRATION NO/DATE: SWISSMEDIC 63223 29.09.2014
57/2014 Austria   Get Started Free PRODUCT NAME: ALBIGLUTID; REGISTRATION NO/DATE: EU/1/13/908/001 UND EU/1/13/908/002 (MITTEILUNG) 20140326
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Baxter
AstraZeneca
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.